Tempo Therapeutics

San Diego, CA · Founded 2013 · Privately Held (backing)

Operator of a life science company intended to harness the power of immunomodulation and material science to transform the landscape of medical technology. Tempo Therapeutics is based in San Diego, CA and was founded in 2013. It has raised $20.7 million across 2 recorded rounds; the latest was a $16.3 million early-stage round in Mar 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$20.7M
Last round
Early Stage VC
Mar 2024
How much has Tempo Therapeutics raised?
$20.7Macross 2 recorded rounds · Jul 2015 – Mar 2024

Most recently, Tempo Therapeutics raised $16.3M in its Early Stage VC (Mar 2024).

Free account
More of Tempo Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Tempo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tempo Therapeutics round by round

2 rounds
Mar 2024Early Stage VC$16.3MSEC filing▮
26 investors participated
Jul 2015Seed Round$3.8MSEC filing▮
39 investors participated

How much has Tempo Therapeutics raised?

Tempo Therapeutics has raised $20.7 million across 2 recorded rounds since 2015. The largest was a $3.8 million seed round in Jul 2015; the most recent was a $16.3 million early-stage round in Mar 2024.

Tempo Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2024 ($16.3 million sold to 26 investors).

Tempo Therapeutics investors

14 investors are on record for Tempo Therapeutics, including US National Science Foundation, MedTech Innovator, National Institutes of Health and CONNECT(San Diego). The early-stage round in Mar 2024 drew 26 investors.

For fundraisers
Raising for a company like Tempo Therapeutics?

14 investors have backed Tempo Therapeutics.

See all 14 investors →

Frequently asked about Tempo Therapeutics

How much has Tempo Therapeutics raised?
Tempo Therapeutics has raised $20.7M in total across 2 recorded funding rounds.
When was Tempo Therapeutics's last funding round?
Tempo Therapeutics's most recent recorded round was Early Stage VC in Mar 2024, raising $16.3M.